Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis

J Nucl Cardiol. 2020 Apr;27(2):688-690. doi: 10.1007/s12350-019-01640-z. Epub 2019 Feb 8.

Authors

Madison B Sharp¹, Aaron Soufer¹, Medhat Abdelmessih¹, Lynda E Rosenfeld¹, Lauren A Baldassarre¹, Edward J Miller²

Affiliations

¹ Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, PO Box 208017, New Haven, CT, 06520-8017, USA.
² Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, PO Box 208017, New Haven, CT, 06520-8017, USA. edward.miller@yale.edu.

PMID: 30737635
DOI: 10.1007/s12350-019-01640-z

No abstract available

Publication types

Case Reports

MeSH terms

Cardiomyopathies / pathology
Female
Fibrosis
Fluorodeoxyglucose F18*
Gadolinium
Heart / diagnostic imaging*
Humans
Imaging, Three-Dimensional
Inflammation
Magnetic Resonance Imaging / methods*
Middle Aged
Multimodal Imaging / methods
Myocardium / pathology*
Positron-Emission Tomography / methods*
Radiopharmaceuticals
Reproducibility of Results
Sarcoidosis / diagnostic imaging*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18
Gadolinium